InsiderTrades

Form 4 for NKTR NEKTAR THERAPEUTICS

Accepted 2025-09-08 00:00:00 ET · period of report 2025-09-04 · accession 0000950170-25-113691 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MT 2025-09-08 2025-09-04+ NKTR ROBIN HOWARD W Pres, CEO, Dir S - Sale $36.42 -11.8K 56.0K -17% -$431.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-04 S D 1,923 $32.37 65,917 D — — (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F2) This transaction was executed in multiple trades at prices ranging from $32.01 to $32.99 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
2 Common Common Stock 2025-09-04 S D 1,496 $33.54 64,421 D — — (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F3) This transaction was executed in multiple trades at prices ranging from $33.02 to $33.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
3 Common Common Stock 2025-09-04 S D 613 $34.40 63,808 D — — (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F4) This transaction was executed in multiple trades at prices ranging from $34.05 to $34.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
4 Common Common Stock 2025-09-04 S D 1,134 $35.80 62,674 D — — (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F5) This transaction was executed in multiple trades at prices ranging from $35.35 to $36.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
5 Common Common Stock 2025-09-05 S D 3,304 $37.87 59,370 D — — (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F6) This transaction was executed in multiple trades at prices ranging from $37.50 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
6 Common Common Stock 2025-09-05 S D 2,226 $38.82 57,144 D — — (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F7) This transaction was executed in multiple trades at prices ranging from $38.50 to $39.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
7 Common Common Stock 2025-09-05 S D 1,136 $39.89 56,008 D — — (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F8) This transaction was executed in multiple trades at prices ranging from $39.50 to $40.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.